COVID-19 Global Rheumatology Alliance 2022, ' Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry ', RMD Open, vol. 8, no. 2, e002508 . https://doi.org/10.1136/rmdopen-2022-002508
NATURE Initiative, COVID H G & Dark, P 2021, ' Mapping the human genetic architecture of COVID-19. ', Nature, vol. 600, no. 7889, pp. 472-477 . https://doi.org/10.1038/s41586-021-03767-x Nature Nature, 600(7889), 472-477. Nature Publishing Group Nature, vol 600, iss 7889 Nature, 600, 472-477. NATURE PORTFOLIO Digital.CSIC. Repositorio Institucional del CSIC instname Nature, Nature Publishing Group, In press, ⟨10.1038/s41586-021-03767-x⟩ COVID-19 Host Genetics Initiative 2021, ' Mapping the human genetic architecture of COVID-19 ', Nature, vol. 600, no. 7889, pp. 472-477 . https://doi.org/10.1038/s41586-021-03767-x Nature, 2021, 600 (7889), pp.472-477. ⟨10.1038/s41586-021-03767-x⟩ Nature, Vol. 600, no. ²7889, p. 472-477 (2021) 472–477 Nature, vol. 600, no. 7889, pp. 472-477 r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol Digibug. Repositorio Institucional de la Universidad de Granada Nature, 600. Nature Publishing Group Nature, 600, 472-477. Nature Publishing Group Niemi, M E K, Karjalainen, J, Liao, R G, Neale, B M, Daly, M, Ganna, A, Pathak, G A, Andrews, S J, Kanai, M, Veerapen, K, Fernandez-Cadenas, I, Schulte, E C, Striano, P, Marttila, M, Minica, C, Marouli, E, Karim, M A, Wendt, F R, Savage, J, Sloofman, L, Butler-Laporte, G, Kim, H-N, Kanoni, S, Okada, Y, Byun, J, Han, Y, Uddin, M J, Smith, G D, Willer, C J, Buxbaum, J D, Karjalainen, J, Mehtonen, J, Folkersen, L, Moltke, I, Hinney, A, Wang, C, Ellinghaus, D, Brunak, S, Castro, P, Guindo-Martinez, M, Lee, J Y, Loos, R J F, Zhao, J H, Sun, Y V, Wang, B, Parker, R, Garcia, S M, Smith, O, Davis, C, COVID-19 Host Genetics Initiative, 23andMe COVID-19 Team, Norwegian SARS-CoV-2 Study Grp, Humanitas COVID-19 Task Force, Humanitas Gavazzeni COVID-19 Task, FHoGID, RegCOVID, P-PredictUs, SeroCOVID, CRiPSI, Genes & Hlth Res Team & UCLA Hlth ATLAS Data Mart Working 2021, ' Mapping the human genetic architecture of COVID-19 ', Nature, vol. 600, pp. 472-477 . https://doi.org/10.1038/s41586-021-03767-x Nature (Lond.) 600 (2021): 472–+. doi:10.1038/s41586-021-03767-x info:cnr-pdr/source/autori:Mari E. K. Niemi; Juha Karjalainen; Rachel G. Liao; Benjamin M. Neale; Mark Daly; Andrea Ganna; COVID-19 Host Genetics Initiative and the GEN-COVID Multicenter Study (including Stella, Alessandra and Biscarini, Filippo)/titolo:Mapping the human genetic architecture of COVID-19/doi:10.1038%2Fs41586-021-03767-x/rivista:Nature (Lond.)/anno:2021/pagina_da:472/pagina_a:+/intervallo_pagine:472–+/volume:600 Ganna, A & Davey Smith, G 2021, ' Mapping the human genetic architecture of COVID-19 ', Nature . https://doi.org/10.1038/s41586-021-03767-x Nature 600, 472-477 (2021) Baillie, J K, Wilson, J F, Bulteel, N, Hayward, C, Klaric, L, Porteous, D J, Russell, C D, Tenesa, A, Norman, L & Scott-Brown, J & Swann, O 2021, ' Mapping the human genetic architecture of COVID-19 ', Nature . https://doi.org/10.1038/s41586-021-03767-x
Annals of the Rheumatic Diseases Annals of the Rheumatic Diseases, BMJ Publishing Group, In press, ⟨10.1136/annrheumdis-2020-219498⟩ Annals of the Rheumatic Diseases, In press, ⟨10.1136/annrheumdis-2020-219498⟩ COVID-19 Global Rheumatology Alliance Consortium & et al. 2021, ' Factors Associated with COVID-19-related Death in People with Rheumatic Diseases: Results from the COVID-19 Global Rheumatology Alliance physician-reported registry ', Annals of the rheumatic diseases, vol. 80, no. 7, pp. 930-942 . https://doi.org/10.1136/annrheumdis-2020-219498 Annals of the rheumatic diseases, vol 80, iss 7 Rheumatology (Oxford, England) Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP
Annals of the Rheumatic Diseases Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418